CPT code 11900 represents an intralesional corticosteroid injection used to treat large nodules, keloids, lichenified hyperkeratotic lesions, and similar localized dermatologic conditions. The code captures a commonly performed, procedure-based intervention in dermatology and surgical specialties that can reduce inflammation, scar tissue, and symptomatic lesion burden. Nationally, this code is relevant because it appears across outpatient dermatology clinics, ambulatory surgical centers, and office-based procedural settings, affecting coverage, documentation, and billing workflows.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes payer coverage patterns and common billing considerations for these organizations. Readers will find concise benchmarks on coding and site-of-service patterns, descriptions of typical clinical contexts in which the code is used, and notes on documentation elements that support medical necessity. Where specific payer policy details are not present in the input, the text indicates "Data not available in the input." The intent is to provide a national-level operational and clinical overview that supports coding accuracy and administrative planning without offering clinical recommendations.